Making a medicine out of MDMA.

@article{Sessa2015MakingAM,
  title={Making a medicine out of MDMA.},
  author={Ben Sessa and David J. Nutt},
  journal={The British journal of psychiatry : the journal of mental science},
  year={2015},
  volume={206 1},
  pages={
          4-6
        }
}
  • B. Sessa, D. Nutt
  • Published 2015
  • Medicine
  • The British journal of psychiatry : the journal of mental science
From its first use 3,4,-methylenedioxymethamphetamine (MDMA) has been recognised as a drug with therapeutic potential. Research on its clinical utility stopped when it entered the recreational drug scene but has slowly resurrected in the past decade. Currently there is enough evidence for MDMA to be removed from its Schedule 1 status of 'no medical use' and moved into Schedule 2 (alongside other misused but useful medicines such as heroin and amphetamine). Such a regulatory move would liberate… Expand
View on PubMed
cambridge.org
26 Citations
Background Citations
10

26 Citations

Citation Type

Citation Type

Psychedelic drugs—a new era in
psychiatry?

  • D. Nutt
  • Medicine
  • Dialogues in clinical neuroscience
  • 2019
TLDR
The renaissance of classical psychedelic drugs such as psilocybin and LSD plus 3,4-methylene dioxymethamphetamine (MDMA—ecstasy) in psychiatric research is covered, which is likely to see these medicines approved for clinical practice soon afterwards. Expand
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
TLDR
Other potential therapeutic applications for MDMA therapy are described, including contemporary studies treating anxiety associated with autism and the authors' ongoing study exploring the potential role for MDMA-assisted psychotherapy to treat alcohol use disorder. Expand
Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder?
Treating people with alcohol use disorder has been an important target area for psychedelic research – both in the first studies of the 1950s and during the Psychedelic Renaissance of the last 10… Expand
The Emerging MDMA Pandemic
TLDR
A new wave of epidemic is emerging that is posing serious mental health risks to people all around the world caused by a club or party drug 3,4-methylenedioxymethamphetamine (MDMA), used primarily as a recreational drug associated with the “rave” culture and, as yet, has no accepted medical uses. Expand
Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.
TLDR
The synthesis of MDMA is detailed as well as its pharmacology, metabolism, adverse effects, and potential use in medicine, which discusses its history and why it is perhaps the most important compound for the future of psychedelic science. Expand
Safety pharmacology of acute MDMA administration in healthy subjects
TLDR
MDMA administration was overall safe in physically and psychiatrically healthy subjects and in a medical setting, however, the risks of MDMA are likely higher in patients with cardiovascular disease and remain to be investigated in Patients with psychiatric disorders. Expand
Why MDMA therapy for alcohol use disorder? And why now?
  • B. Sessa
  • Psychology, Medicine
  • Neuropharmacology
  • 2018
TLDR
It is proposed in a current on‐going UK‐based study that patients with alcohol use disorder who have undergone a medical detoxification from alcohol might benefit from a course of MDMA‐assisted psychotherapy. Expand
Motor delays in MDMA (ecstasy) exposed infants persist to 2 years.
TLDR
Infants whose mothers reported heavier MDMA use during pregnancy had motor delays from 4 months to two years of age that were not attributable to other drug or lifestyle factors and women of child bearing age should be cautioned about the use of MDMA and MDMA-exposed infants should be screened for motor delays and possible intervention. Expand
A psychological exploration of long-term LSD users
All research involving the psychoactive compound lysergic acid diethylamide (LSD) was terminated globally following its prohibition more than 50 years ago, though illicit use remained fairly stable.… Expand
Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary
Underground psychedelic-assisted psychotherapy has persisted in Europe despite the banning of the substances LSD and MDMA in the 1960s and 1980s, respectively. This article describes the work of a… Expand
...
1
2
3
...

References

SHOWING 1-10 OF 19 REFERENCES
Could MDMA be useful in the treatment of post‐traumatic stress disorder?
TLDR
Dr Sessa discusses controversies and describes a UK‐based MDMA/PTSD currently in development, which she describes as an adjunct to post‐trauma psychological therapy. Expand
Brain serotonin transporter binding in former users of MDMA ('ecstasy').
TLDR
To the extent that [(11)C]DASB binding provides an index of the integrity of serotonin neurons, the findings suggest that MDMA use may not result in long-term damage to serotonin neurons when used recreationally in humans. Expand
Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing
TLDR
The present findings provide only limited support for the idea that oxytocin produces the prosocial effects of MDMA, which increases euphoria and feelings of sociability. Expand
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
TLDR
MDMA-assisted psychotherapy can be administered to posttraumatic stress disorder patients without evidence of harm, and it may be useful in patients refractory to other treatments. Expand
Subjective reports of the effects of MDMA in a clinical setting.
TLDR
The psychological effects of MDMA were first relaboratory of Alexander Shulgin, Ph.D., who had colported in 1978 by Shulkin and Nichols and was no synthesis, and was synthesized in the actual or possible pregnancy. Expand
MDMA effects consistent across laboratories
TLDR
The subjective and physiological responses to the drug across three different laboratories and the influence of prior MDMA use indicate that the pharmacological effects of MDMA are robust and highly reproducible across settings. Expand
A Window into the Intoxicated Mind? Speech as an Index of Psychoactive Drug Effects
Abused drugs can profoundly alter mental states in ways that may motivate drug use. These effects are usually assessed with self-report, an approach that is vulnerable to biases. Analyzing speech… Expand
MDMA alters emotional processing and facilitates positive social interaction
TLDR
MDMA alters basic emotional processes by slowing identification of negative emotions and increasing responses to positive emotions in others, and positively affects behavior and perceptions during actual social interaction. Expand
A reconsideration and response to Parrott AC (2013) “Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research”
TLDR
Though it critiques an attempt by other authors to characterize the risks of MDMA, the review fails to produce a competing model of risk assessment, and does not discuss potential benefits, which may deter researchers from further investigating an innovative treatment. Expand
MDMA decreases the effects of simulated social rejection
TLDR
A cognitive mechanism by which MDMA might produce pro-social behavior and feelings is suggested and how the drug might function as an adjunct to psychotherapy is suggested, both of which merit further study in non-simulated social environments. Expand
...
1
2
...